285 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
LGND Ligand Pharmaceuticals Incorporated $135.56 $2.85B N/A
Article Searches
Biotech Stocks Are Tariff-Safe And Building Momentum https://seekingalpha.com/article/4189138-biotech-stocks-tariff-safe-building-momentum?source=feed_all_articles Jul 23, 2018 - The Nasdaq Biotechnology Index is poised to make a 52-week high and most likely an all-time high shortly thereafter. Biotech stocks are more insulated from the biggest concern for the market - the tar
Intuitive Surgical: Potentially Attractive Entry Point Following Any Post-2Q18 Sell Off https://seekingalpha.com/article/4188196-intuitive-surgical-potentially-attractive-entry-point-following-postminus-2q18-sell?source=feed_sector_healthcare Jul 18, 2018 - Intuitive Surgical is experiencing strong operating momentum and positive consensus estimate momentum, and despite its high trading multiple we think the stock has upside potential. The stock was adde
Madrigal Is Unreasonably Priced For Perfection And Limited Competition https://seekingalpha.com/article/4188179-madrigal-unreasonably-priced-perfection-limited-competition?source=feed_sector_healthcare Jul 18, 2018 - Madrigal's valuation seems bloated following positive phase 2 NASH data. At the least, it is certainly difficult to argue shares are undervalued. NASH is currently a completely open field, but not for
Cheap Stocks Moving In The Right Direction https://seekingalpha.com/article/4188010-cheap-stocks-moving-right-direction?source=feed_all_articles Jul 18, 2018 - What can be better than buying a cheap stock? Buying a cheap stock that is moving in the right direction.Introducing a quantitative system focused on companies with low PEG ratio and rising earnings e
Playing The Expectations Game In Biotech https://seekingalpha.com/article/4187892-playing-expectations-game-biotech?source=feed_all_articles Jul 17, 2018 - The biotechnology sector is fertile ground for highly profitable investments, but the downside risk in the sector is also above average.Since the dispersion in returns is so wide, picking the right in
Covenant Asset Management, LLC Buys Ligand Pharmaceuticals Inc, Proto Labs Inc, Intuitive ... http://www.gurufocus.com/news/707276/covenant-asset-management-llc-buys-ligand-pharmaceuticals-inc-proto-labs-inc-intuitive-surgical-inc-sells-huntington-ingalls-industries-inc-regions-financial-corp-honeywell-international-inc Jul 12, 2018 - Covenant Asset Management, LLC Buys Ligand Pharmaceuticals Inc, Proto Labs Inc, Intuitive Surgical Inc, Sells Huntington Ingalls Industries Inc, Regions Financial Corp, Honeywell International Inc, Stocks: V,ILMN,EEM,CSCO,VCSH,LGND,PRLB,ISRG,NOC,NOW,STZ,HO, release date:Jul 12, 2018
HZNP vs. LGND: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/310864/hznp-vs-lgnd-which-stock-is-the-better-value-option?cid=CS-ZC--310864 Jul 10, 2018 - HZNP vs. LGND: Which Stock Is the Better Value Option?
By The Numbers: Growth Leaders With Rising Earnings Expectations https://seekingalpha.com/article/4186079-numbers-growth-leaders-rising-earnings-expectations?source=feed_all_articles Jul 09, 2018 - Investing in high growth stocks can generate outstanding returns over the long term. The following article presents a quantitative investing system based on identifying consistent growth leaders with
Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up http://www.zacks.com/stock/news/306176/kitov-ktov-gets-approval-from-fda-for-consensi-shares-up?cid=CS-ZC-FT-306176 Jun 01, 2018 - Kitov Pharma (KTOV) gained as the FDA approved Consensi (amlodipine and celecoxib) oral tablets for the treatment of osteoarthritis pain and hypertension.
"Right To Try" Brings Good News for Biotech Sector: 5 Picks http://www.zacks.com/stock/news/305964/right-to-try-brings-good-news-for-biotech-sector-5-picks?cid=CS-ZC-FT-305964 Jun 01, 2018 - Passage of the Right To Try law and WHO's focus on assessing the quality of bio-similar drugs is expected to benefit biotech stocks.

Pages: 123456...29

Page 1>

Related Companies

Name Exchange Price Mkt Cap
SRPT Sarepta Therapeutics, Inc. NASDAQ $45.175 $2.91B
GWPH GW Pharmaceuticals Plc NASDAQ $108.375 $2.74B
AXON Axovant Sciences Ltd. NASDAQ $25 $2.69B
PBH Prestige Brand Holdings, Inc. NYSE $49.11 $2.6B
LOXO Loxo Oncology, Inc. NASDAQ $86.82 $2.59B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Ligand Pharmaceuticals Incorporated